UK Epithelioma Treatment Market Size & Outlook, 2025-2030
Related Markets
UK epithelioma treatment market highlights
- The UK epithelioma treatment market generated a revenue of USD 176.7 million in 2024 and is expected to reach USD 341.5 million by 2030.
- The UK market is expected to grow at a CAGR of 11.6% from 2025 to 2030.
- In terms of segment, basal cell epithelioma was the largest revenue generating type in 2024.
- Squamous Cell Epithelioma is the most lucrative type segment registering the fastest growth during the forecast period.
Epithelioma treatment market data book summary
| Market revenue in 2024 | USD 176.7 million |
| Market revenue in 2030 | USD 341.5 million |
| Growth rate | 11.6% (CAGR from 2025 to 2030) |
| Largest segment | Basal cell epithelioma |
| Fastest growing segment | Squamous Cell Epithelioma |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Basal Cell Epithelioma, Squamous Cell Epithelioma |
| Key market players worldwide | Bristol-Myers Squibb Co, Merck & Co Inc, Novartis AG ADR, Amgen Inc, Pfizer Inc, Sanofi SA, Johnson & Johnson, Roche Holding AG ADR |
Other key industry trends
- In terms of revenue, UK accounted for 3.3% of the global epithelioma treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany epithelioma treatment market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 341.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epithelioma Treatment Market Scope
Epithelioma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
UK epithelioma treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epithelioma treatment market will help companies and investors design strategic landscapes.
Basal cell epithelioma was the largest segment with a revenue share of 67.74% in 2024. Horizon Databook has segmented the UK epithelioma treatment market based on basal cell epithelioma, squamous cell epithelioma covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UK epithelioma treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK epithelioma treatment market databook
-
Our clientele includes a mix of epithelioma treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK epithelioma treatment market , including forecasts for subscribers. This country databook contains high-level insights into UK epithelioma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK epithelioma treatment market size, by drug class, 2018-2030 (US$M)
UK Epithelioma Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
